Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF DILUTIVE COMMON STOCK EQUIVALENTS (Details) (Parenthetical)

v3.21.2
SCHEDULE OF DILUTIVE COMMON STOCK EQUIVALENTS (Details) (Parenthetical) - Convertible Notes Payable [Member] - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock issuable upon conversion, shares 0 1,152,411
Common stock issuable upon conversion   $ 1,152,411
Debt conversion price per share   $ 1.00
Beneficial ownership limitations percentage   9.99%